Paradigm shift in neuroprotective drug development: clinically tolerated NMDA receptor inhibition by memantine.

Authors :: Lipton SA
Chen HS
Source :: Cell death and differentiation [Cell Death Differ] 2004 Jan; Vol. 11 (1), pp. 18-20.
Publication Year :: 2004

Subjects :: Drug Delivery Systems methods
Humans
Memantine therapeutic use
Neuroprotective Agents therapeutic use
Dementia drug therapy
Drug Design
Memantine pharmacology
Neuroprotective Agents pharmacology
Receptors, N-Methyl-D-Aspartate antagonists & inhibitors

Full Text Access

Tools